MADELINE O'HARA-MOFFO: Open Payments
NPI 1407916307 · CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 21 payments from 13 companies in 2025. Trend: 2023 $378 · 2024 $236 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $133 |
| GENZYME CORPORATION | 3 | $67 |
| ABBVIE INC. | 2 | $61 |
| QOL Medical, LLC | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $20 |
| Sandoz Inc. | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $19 |
Products named: REZDIFFRA, XIFAXAN, DUPIXENT, CREON, Sucraid, IQIRVO, IBSRELA, HYRIMOZ.
Industry payments across PA — which companies pay providers there.
